All analyses were conducted with Stata/IC, version 14.2 (StataCorp LP) or SAS, version 9.4 (SAS Institute). in undertreatment of high-risk patients. A novel method (Martin/Hopkins) using a patient-specific conversion factor provides more accurate LDL-C levels. However, this method has not been tested in proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitorCtreated […]